TY - JOUR
T1 - Antigen cross-presentation by dendritic cell subsets
T2 - One general or all sergeants?
AU - Nierkens, Stefan
AU - Tel, Jurjen
AU - Janssen, Edith
AU - Adema, Gosse J.
N1 - Funding Information:
Limitations of space preclude extensive citation of the literature; we apologize to those whose work is not mentioned in this review. This work was supported by grants from the Dutch Cancer Society ( KWF2008-4617 ), The Netherlands Organization for Scientific Research ( NWO-Vici-918.66.615 ), and the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908 ).
PY - 2013/8
Y1 - 2013/8
N2 - Antigen cross-presentation describes the process through which dendritic cells (DCs) acquire exogenous antigens for presentation on MHC class I molecules. The ability to cross-present has been thought of as a feature of specialized DC subsets. Emerging data, however, suggest that the cross-presenting ability of each DC subset is tuned by and dependent on several factors, such as DC location and activation status, and the type of antigen and inflammatory signals. Thus, we argue that capacity of cross-presentation is not an exclusive trait of one or several distinct DC subtypes, but rather a common feature of the DC family in both mice and humans. Understanding DC subset activation and antigen-presentation pathways might yield improved tools and targets to exploit the unique cross-presenting capacity of DCs in immunotherapy.
AB - Antigen cross-presentation describes the process through which dendritic cells (DCs) acquire exogenous antigens for presentation on MHC class I molecules. The ability to cross-present has been thought of as a feature of specialized DC subsets. Emerging data, however, suggest that the cross-presenting ability of each DC subset is tuned by and dependent on several factors, such as DC location and activation status, and the type of antigen and inflammatory signals. Thus, we argue that capacity of cross-presentation is not an exclusive trait of one or several distinct DC subtypes, but rather a common feature of the DC family in both mice and humans. Understanding DC subset activation and antigen-presentation pathways might yield improved tools and targets to exploit the unique cross-presenting capacity of DCs in immunotherapy.
KW - Antigen presentation
KW - Cross-presentation
KW - Dendritic cell subsets
KW - Immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=84881025018&partnerID=8YFLogxK
U2 - 10.1016/j.it.2013.02.007
DO - 10.1016/j.it.2013.02.007
M3 - Review article
C2 - 23540650
AN - SCOPUS:84881025018
SN - 1471-4906
VL - 34
SP - 361
EP - 370
JO - Trends in Immunology
JF - Trends in Immunology
IS - 8
ER -